Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

SubscribeLogin
Published • loading... • Updated

Startup promising to scale custom CRISPR therapies abruptly scraps plans

Summary by STAT
Personalized gene-editing startup co-founded by Jennifer Doudna, facing stiff competition, IP hurdles and production issues, closes custom PKU drug program.

1 Articles

STATSTAT
Center

Startup promising to scale custom CRISPR therapies abruptly scraps plans

Personalized gene-editing startup co-founded by Jennifer Doudna, facing stiff competition, IP hurdles and production issues, closes custom PKU drug program.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Tuesday, August 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups icon

Startups

CRISPR icon

CRISPR

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal